Quick infos Headquarters: Netherlands Trade prices Volume: Market Cap: 784.05M Prev closed: Open: 15.76 High: 16.01 Low: 15.51 52 week low: 13.14 52 week high: 42.86 Dividends: No Dividends Next ER: August 7, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 24, 2023 April 27, 2023 - / -0.651- / -December 8, 2022 -0.2371 / -0.6357- / -September 12, 2022 -0.38 / -0.5669- / -July 29, 2022 - / -0.485- / -view more
Historical Data Date Price Open High Low Vol Change ER May 24, 2022 17.00 16.50 17.15
16.50
7.99K 0% May 23, 2022 17.00 17.00 17.00
17.00
0.19K 0% May 20, 2022 17.00 16.89 17.00
16.40
2.26K 1.80% May 19, 2022 16.70 16.98 16.98
16.70
1.16K -1.07% May 18, 2022 16.88 16.78 17.28
16.62
6.40K -3.82% May 17, 2022 17.55 17.10 17.55
17.10
3.78K 2.57% May 16, 2022 17.11 17.30 17.35
16.90
8.59K -0.81% May 13, 2022 17.25 18.00 18.00
17.25
4.08K 1.35% May 12, 2022 17.02 16.50 17.02
16.50
2.22K 4.10% May 11, 2022 16.35 16.74 16.74
16.35
0.77K -0.3% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com Aug 16, 2023 6:51 am
Pharvaris Announces FDA Removal of Clinical Hold of Deucrictibant for the On-Demand Treatment of HAE finance.yahoo.com Aug 16, 2023 6:50 am
Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls finance.yahoo.com Aug 15, 2023 9:59 am
Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit finance.yahoo.com Jul 21, 2023 10:20 am
Why Shares of Pharvaris N.V. Are Up Tuesday finance.yahoo.com Jun 27, 2023 12:11 pm
Wall Street Analysts Predict an 88.24% Upside in Pharvaris N.V. (PHVS): Here's What You Should Know finance.yahoo.com May 17, 2023 9:55 am
We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth finance.yahoo.com Mar 20, 2023 3:31 pm
Why Pharvaris Shares Are Plummeting Today? finance.yahoo.com Dec 9, 2022 3:45 pm
Pharvaris Reports First Quarter 2022 Financial Results and Provides Business Highlights finance.yahoo.com Dec 9, 2022 8:10 am
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks finance.yahoo.com Dec 9, 2022 6:50 am CDLX, RXT and BIVI among mid-day movers seekingalpha.com Dec 9, 2022 2:11 am Pharvaris, Incannex top healthcare gainers; Eiger, Relmada among losers seekingalpha.com Dec 8, 2022 11:00 pm Pharvaris GAAP EPS of -€0.25 seekingalpha.com Dec 8, 2022 9:29 pm
Data of Deucrictibant for the On-Demand Treatment of HAE Attacks Presented at the EAACI Congress 2023 finance.yahoo.com Jun 10, 2023 6:01 pm
Deucrictibant Data Highlighted in Multiple Presentations at the C1-Inhibitor Deficiency and Angioedema Workshop finance.yahoo.com May 6, 2023 1:00 pm
Pharvaris to Present in Upcoming March Investor Conferences finance.yahoo.com Mar 2, 2023 6:50 am
Pharvaris to Present at SVB Securities Global Biopharma Conference finance.yahoo.com Feb 8, 2023 6:50 am
Pharvaris Provides Regulatory, Clinical, and Corporate Updates finance.yahoo.com Jan 9, 2023 6:50 am Pharvaris adds 58% on positive data from mid-stage hereditary angioedema trial seekingalpha.com Dec 8, 2022 9:08 pm
Pharvaris Shares Surges On Positive Data From HAE Attacks Study, Makes Way For FDA To Remove Clinical Hold finance.yahoo.com Dec 8, 2022 1:15 pm This company doesn't provide a dividend.
Talk about Pharvaris below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology